Prognostic Significance of Serum Magnesium in Acute Intracerebral Hemorrhage Patients

Author(s): Xianjun Han, Shoujiang You, Zhichao Huang, Qiao Han, Chongke Zhong, Jiaping Xu, Rongfang Shi, Dongqin Chen, Yanlin Zhang, Guodong Xiao*, Yongjun Cao, Chun-Feng Liu*

Journal Name: Current Neurovascular Research

Volume 16 , Issue 2 , 2019

Become EABM
Become Reviewer
Call for Editor


Background: Experimental animal model studies have shown neuroprotective properties of magnesium. We assessed the relationship between admission magnesium and admission stroke severity and 3-month clinical outcomes in patients with acute intracerebral hemorrhage (ICH).

Methods: The present study included 323 patients with acute ICH who were prospectively identified. Demographic characteristics, lifestyle risk factors, National Institute of Health Stroke Scale (NIHSS) score, hematoma volumes, and other clinical features were recorded at baseline for all participants. Patients were divided into three groups based on the admission magnesium levels (T1: <0.84; T2: 0.84-0.91; T3: ≥0.91 mmol/L). Clinical outcomes were death, poor functional outcome (defined by modified rankin ccale [mRS] scores 3-6) at 3 months.

Results: After 3-month follow-up, 40 (12.4%) all-cause mortality and 132 (40.9%) poor functional outcome were documented. Median NIHSS scores for each tertile (T1 to T3) were 8.0, 5.5, and 6.0, and median hematoma volumes were 10.0, 8.05, and 12.4 ml, respectively. There was no significant association between baseline NIHSS scores (P=0.176) and hematoma volumes (P=0.442) in T3 and T1 in multivariable linear regression models. Compared with the patients in T1, those in T3 were associated with less frequency of all-cause mortality [adjusted odds ratio (OR), 0.10; 95% confidence interval (CI), 0.02-0.54; P-trend=0.010] but not poor functional outcome (adjusted OR, 1.80; 95%CI, 0.71-4.56; P-trend=0.227) after adjustment for potential confounders.

Conclusion: Elevated admission serum magnesium level is associated with lower odds of mortality but not poor functional outcome at 3 months in patients with acute ICH.

Keywords: Serum magnesium, intracerebral hemorrhage (ICH), prognosis, risk factor, mortality, hematoma volume.

Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013; 368: 2355-65.
Lovelock C, Molyneux A, Rothwell P. Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol 2007; 6: 487-93.
Muir K. Magnesium for neuroprotection in ischaemic stroke: Rationale for use and evidence of effectiveness. CNS Drugs 2001; 15: 921-30.
Marinov M, Harbaugh K, Hoopes P, Pikus H, Harbaugh R. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg 1996; 85: 117-24.
Song Y, Li T, van Dam R, Manson J, Hu F. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr 2007; 85: 1068-74.
Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 1984; 307: 462-5.
Ascherio A, Rimm E, Hernán M, et al. Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation 1998; 98: 1198-204.
Sluijs I, Czernichow S, Beulens JW, et al. Intakes of potassium, magnesium, and calcium and risk of stroke. Stroke 2014; 45: 1148-50.
Akarolo-Anthony S, Jiménez M, Chiuve S, Spiegelman D, Willett W, Rexrode K. Plasma magnesium and risk of ischemic stroke among women. Stroke 2014; 45: 2881-6.
Larsson S, Orsini N, Wolk A. Dietary magnesium intake and risk of stroke: a meta-analysis of prospective studies. Am J Clin Nutr 2012; 95: 362-6.
Bayir A, Ak A, Kara H, Sahin T. Serum and cerebrospinal fluid magnesium levels, Glasgow Coma Scores, and in-hospital mortality in patients with acute stroke. Biol Trace Elem Res 2009; 130: 7-12.
Behrouz R, Hafeez S, Mutgi S, Zakaria A, Miller C. Hypomagnesemia in Intracerebral Hemorrhage. World Neurosurg 2015; 84: 1929-32.
You S, Zhong C, Xu J, et al. LDL-C/HDL-C ratio and risk of all-cause mortality in patients with intracerebral hemorrhage. Neurol Res 2016; 38: 903-8.
Sun Y, You S, Zhong C, et al. Neutrophil to lymphocyte ratio and the hematoma volume and stroke severity in acute intracerebral hemorrhage patients. Am J Emerg Med 2017; 35: 429-33.
Kothari R, Brott T, Broderick J, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996; 27: 1304-5.
Carcel C, Sato S, Zheng D, et al. Prognostic Significance of Hyponatremia in Acute Intracerebral Hemorrhage: Pooled Analysis of the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Studies. Crit Care Med 2016; 44: 1388-94.
You S, Zhong C, Du H, et al. Admission Low Magnesium Level Is Associated with In-Hospital Mortality in Acute Ischemic Stroke Patients. Cerebrovasc Dis 2017; 44: 35-42.
Liotta E, Prabhakaran S, Sangha R, et al. Magnesium, hemostasis, and outcomes in patients with intracerebral hemorrhage. Neurology 2017; 89: 813-9.
Forti P, Maioli F, Domenico Spampinato M, et al. The Effect of Age on Characteristics and Mortality of Intracerebral Hemorrhage in the Oldest-Old. Cerebrovasc Dis 2016; 42: 485-92.
Saxena A, Anderson CS, Wang X, et al. Prognostic Significance of Hyperglycemia in Acute Intracerebral Hemorrhage: The INTERACT2 Study. Stroke 2016; 47: 682-8.
Bejot Y, Aboa-Eboule C, Hervieu M, et al. The deleterious effect of admission hyperglycemia on survival and functional outcome in patients with intracerebral hemorrhage. Stroke 2012; 43: 243-5.
Chi O, Pollak P, Weiss H. Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat. Arch Int Pharmacodyn Ther 1990; 304: 196-205.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2019
Published on: 12 April, 2019
Page: [123 - 128]
Pages: 6
DOI: 10.2174/1567202616666190412124539
Price: $65

Article Metrics

PDF: 41